Adverse Effects of Recreational and Medical Cannabis
Cannabis use has become more abundant for both medical and recreational use. It carries likely benefits in the form of analgesia, anti-emesis and improved appetite in chronic patients. The evidence reviewing adverse effects of this use are still limited, however, exiting data points to a clear link with neurocognitive deterioration, backed by loss of brain volume and density. Addiction is likely complex and variable, and no good data exists to support treatment at this point. It is becoming clear that use in earlier ages carries a higher risk for long-term deficits. As with any other drug, these risks should be considered alongside benefits prior to a decision on cannabis use.
Authors
- Elyse M. Cornett (ORCID: https://orcid.org/0000-0001-7961-3931)
- Kyle Gress (ORCID: https://orcid.org/0000-0002-9142-2553)
- Omar Viswanath (ORCID: https://orcid.org/0000-0002-6124-7037)
- Alan D. Kaye (ORCID: https://orcid.org/0000-0003-2464-0187)
- Karina Charipova (ORCID: https://orcid.org/0000-0002-6337-3766)
- Amnon A. Berger (ORCID: https://orcid.org/0000-0001-7895-1357)
- Nathan Li (ORCID: https://orcid.org/0000-0002-4918-0060)
- Hisham Kassem (ORCID: https://orcid.org/0000-0002-3729-1900)
- Ivan Urits (ORCID: https://orcid.org/0000-0002-3652-6085)
- Anh L. Ngo (ORCID: https://orcid.org/0009-0000-9709-9534)
Institutions
- Georgetown University (US)
- Mount Sinai Medical Center (US)
- Louisiana State University Health Sciences Center New Orleans (US)
Publication Details
- Journal
- Psychopharmacology Bulletin
- Published
- 2025-08-12
- DOI
- https://doi.org/10.64719/pb.4395
- Citations
- 73
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 39.05